back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-29 19:54 Tx date 2024-04-19 |
$IGX
IntelGenx Technologies Corp. |
atai Life Sciences AG
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Loan Agreement
11 - Acquisition or disposition carried out privately
|
+$1,000,000 vol |
$10,500,000 | |
| Filed 2024-03-13 07:42 Tx date 2024-03-08 |
$IGX
IntelGenx Technologies Corp. |
atai Life Sciences AG
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options Call Option
11 - Acquisition or disposition carried out privately
|
+7,401 vol |
7,401 | |
| Filed 2024-03-13 07:37 Tx date 2021-03-17 |
$IGX
IntelGenx Technologies Corp. |
atai Life Sciences AG
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options Call Option
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-13 07:34 Tx date 2024-03-08 |
$IGX
IntelGenx Technologies Corp. |
atai Life Sciences AG
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Loan Agreement
11 - Acquisition or disposition carried out privately
|
+$9,500,000 vol |
$9,500,000 | |
| Filed 2024-03-13 07:31 Tx date 2021-03-17 |
$IGX
IntelGenx Technologies Corp. |
atai Life Sciences AG
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Loan Agreement
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-11 17:31 Tx date 2024-03-11 |
$IGX
IntelGenx Technologies Corp. |
atai Life Sciences AG
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+4,000,000 vol |
42,432,850 | |
| Filed 2023-12-11 16:16 Tx date 2023-12-04 |
$IGX
IntelGenx Technologies Corp. |
atai Life Sciences AG
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+4,053,750 vol |
38,432,850 | |
| Filed 2023-12-11 16:13 Tx date 2023-12-04 |
$IGX
IntelGenx Technologies Corp. |
atai Life Sciences AG
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Notes August 31 2023
16 - Acquisition or disposition under a prospectus exemption
|
+$750,000 vol |
$2,970,000 | |
| Filed 2023-09-05 17:29 Tx date 2023-08-31 |
$IGX
IntelGenx Technologies Corp. |
atai Life Sciences AG
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+11,999,100 vol |
34,379,100 | |
| Filed 2023-09-05 17:26 Tx date 2023-08-31 |
$IGX
IntelGenx Technologies Corp. |
atai Life Sciences AG
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Notes August 31 2023
16 - Acquisition or disposition under a prospectus exemption
|
+$2,220,000 vol |
$2,220,000 | |
| Filed 2023-09-05 17:17 Tx date 2021-03-17 |
$IGX
IntelGenx Technologies Corp. |
atai Life Sciences AG
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Notes August 31 2023
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-05 17:09 Tx date 2021-03-17 |
$IGX
IntelGenx Technologies Corp. |
atai Life Sciences AG
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Notes August 31 2023
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-05 17:07 Tx date 2021-03-17 |
$IGX
IntelGenx Technologies Corp. |
atai Life Sciences AG
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Notes August 31 2023
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-21 14:35 Tx date 2021-05-14 |
$IGX
IntelGenx Technologies Corp. |
atai Life Sciences AG
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+22,380,000 vol |
22,380,000 | |
| Filed 2021-05-21 14:34 Tx date 2021-05-14 |
$IGX
IntelGenx Technologies Corp. |
atai Life Sciences AG
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$12,346,300
+37,300,000 vol $0.331 each |
37,300,000 | |
| Filed 2021-05-21 14:20 Tx date 2021-03-17 |
$IGX
IntelGenx Technologies Corp. |
atai Life Sciences AG
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-21 14:20 Tx date 2021-03-17 |
$IGX
IntelGenx Technologies Corp. |
atai Life Sciences AG
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-18 13:48 Tx date 2021-03-17 |
$IGX
IntelGenx Technologies Corp. |
atai Life Sciences AG
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-18 13:48 Tx date 2021-03-17 |
$IGX
IntelGenx Technologies Corp. |
atai Life Sciences AG
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-18 13:48 Tx date 2021-03-17 |
$IGX
IntelGenx Technologies Corp. |
atai Life Sciences AG
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
22,380,000 | ||
| Filed 2021-03-18 13:48 Tx date 2021-03-17 |
$IGX
IntelGenx Technologies Corp. |
atai Life Sciences AG
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
37,300,000 |